These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4401077)

  • 41. Cyclical phenomena in persistent virus infection.
    Hotchin J
    J Reticuloendothel Soc; 1974 Apr; 15(4):304-11. PubMed ID: 4134995
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of liposomal charge on the neutralizing antibody response against inactivated encephalomyocarditis and Semliki Forest viruses.
    Kraaijeveld CA; Schilham M; Jansen J; Benaissa-Trouw B; Harmsen M; van Houte AJ; Snippe H
    Clin Exp Immunol; 1984 Jun; 56(3):509-14. PubMed ID: 6086188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunofluorescent studies on the effect of antiviral substances on virus multiplication. II. Determination of fluorescence intensity in Mengo virus infected L cells treated with beta-2-DL-thienylalanine.
    Augsten K; Veckenstedt A; Wagner M
    Arch Gesamte Virusforsch; 1971; 33(1):41-8. PubMed ID: 4325975
    [No Abstract]   [Full Text] [Related]  

  • 44. [Immunofluorescent study of the specificity of the hexon determinants in adenovirus-infected cells].
    Nosach LN
    Mikrobiol Zh (1978); 1982; 44(5):65-70. PubMed ID: 6183563
    [No Abstract]   [Full Text] [Related]  

  • 45. Different pH requirements for entry of the two picornaviruses, human rhinovirus 2 and murine encephalomyocarditis virus.
    Madshus IH; Olsnes S; Sandvig K
    Virology; 1984 Dec; 139(2):346-57. PubMed ID: 6097029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Some properties of temperature-sensitive mutants of poliovirus in two cell lines.
    Yakobson EA; Mikheyeva AV; Ghendon YZ
    Acta Virol; 1972 Jul; 16(4):345-8. PubMed ID: 4403177
    [No Abstract]   [Full Text] [Related]  

  • 47. [Stability of cytoplasmic poly-(A)-containing RNAs in cells infected with encephalomyocarditis virus].
    Ginevskaia VA; Svitkin IuV; Ugarova TIu; Agol VI
    Dokl Akad Nauk SSSR; 1974; 219(2):477-80. PubMed ID: 4374345
    [No Abstract]   [Full Text] [Related]  

  • 48. Virus-induced diabetes mellitus. X. Attachment of encephalomyocarditis virus and permissiveness of cultured pancreatic beta cells to infection.
    Chairez R; Yoon JW; Notkins AL
    Virology; 1978 Apr; 85(2):606-11. PubMed ID: 208240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Preparation and use of diagnostic serum for identification of herpes simplex virus].
    Popova RD
    Lab Delo; 1982; (4):252-3. PubMed ID: 6177921
    [No Abstract]   [Full Text] [Related]  

  • 50. Encephalomyocarditis (EMC) virus-induced sialodacryoadenitis in mice.
    Ohguchi A; Nakayama Y; Doi C; Nakayama H; Doi K
    Exp Mol Pathol; 2005 Feb; 78(1):58-63. PubMed ID: 15596062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells.
    Cho MW; Teterina N; Egger D; Bienz K; Ehrenfeld E
    Virology; 1994 Jul; 202(1):129-45. PubMed ID: 8009827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid plaque assay for encephalomyocarditis virus.
    Baker DA; Glasgow LA
    Appl Microbiol; 1969 Nov; 18(5):932-4. PubMed ID: 4313172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specific cleavage of viral proteins as steps in the synthesis and maturation of enteroviruses.
    Holland JJ; Kiehn ED
    Proc Natl Acad Sci U S A; 1968 Jul; 60(3):1015-22. PubMed ID: 4299264
    [No Abstract]   [Full Text] [Related]  

  • 54. Induction of membrane proliferation by poliovirus proteins 2C and 2BC.
    Aldabe R; Carrasco L
    Biochem Biophys Res Commun; 1995 Jan; 206(1):64-76. PubMed ID: 7818552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of Friend leukemia virus (FLV) and some arboviruses in tissue culture.
    Pogodina VV; Senyuta NB; Merekalova ZI; Mazurenko NP
    Neoplasma; 1974; 21(3):267-74. PubMed ID: 4608955
    [No Abstract]   [Full Text] [Related]  

  • 56. Protective effects of macrophage-derived interferon against encephalomyocarditis virus-induced diabetes mellitus in mice.
    Hirasawa K; Ogiso Y; Takeda M; Lee MJ; Itagaki S; Doi K
    Lab Anim Sci; 1995 Dec; 45(6):652-6. PubMed ID: 8746525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutants of encephalomyocarditis virus requiring a hypertonic environment for optimal growth in HeLa cells.
    Maslova SV; Lipskaya GYu ; Agol VI
    Virology; 1982 Oct; 122(1):125-33. PubMed ID: 6291232
    [No Abstract]   [Full Text] [Related]  

  • 58. The prevalence of encephalomyocarditis virus neutralizing antibodies among various human populations.
    Tesh RB
    Am J Trop Med Hyg; 1978 Jan; 27(1 Pt 1):144-9. PubMed ID: 204206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and characterization of the cell surface 70-kilodalton sialoglycoprotein(s) as a candidate receptor for encephalomyocarditis virus on human nucleated cells.
    Jin YM; Pardoe IU; Burness AT; Michalak TI
    J Virol; 1994 Nov; 68(11):7308-19. PubMed ID: 7933115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic infection of HeLa cells with Japanese encephalitis virus. General characteristics of the system.
    Loginova NV; Deryabin PG; Mikhailova GR; Tsareva AA; Buinitskaya OB
    Acta Virol; 1980 Dec; 24(6):399-405. PubMed ID: 6111200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.